Accession Number: | 0001628280-21-012178 |
Date: | 2021-06-10 |
Issuer: | CARDIFF ONCOLOGY, INC. (CRDF) |
Original Submission Date: |
WHITE LALE
C/O CARDIFF ONCOLOGY, INC.
11055 FLINTKOTE AVENUE
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTIONS | 7.98 | 2021-06-10 | deemed execution date | A | 22,000 (a) | 2022-06-10 | 2031-06-10 | common stock 22,000 | $7.98 | 62,774 | direct |
ID | footnote |
---|